Dr Reddy's Lab said today that all the litigation claims against the company over Revlimid have been dismissed in the USA court.
In Nov 2022, Antitrust case filed against Dr Reddys Labs in the US over maintaining a shared monopoly in the sale of brand and generic Revlimid through their respective settlements of patent litigation with other pharmaceutical companies.
source https://www.pharmatutor.org/pharma-news/2022/revlimid-antitrust-case-against-dr-reddys-lab-is-dismissed-in-us
No comments:
Post a Comment